Le Lézard
Classified in: Health
Subjects: CHI, STP

Senators Rubio, Bennet Partner with the St. Baldrick's Foundation for Pediatric Oncology Immunotherapy Senate Briefing


WASHINGTON, Oct. 25, 2017 /PRNewswire-USNewswire/ -- Senators Marco Rubio (R-FL) and Michael Bennet (D-CO) partnered with the St. Baldrick's Foundation ? the largest private funder of childhood cancer research grants ? for its luncheon briefing on the Hill today. The senators acted as honorary Congressional hosts for a variety of panels covering advances in immunotherapy and pediatric oncology research, and the challenges and opportunities in drug development and treatment.

St. Baldrick's Foundation, the largest private funder of childhood cancer research grants. (PRNewsFoto/St. Baldrick's Foundation)

The panels were moderated by Jeffrey M. Lipton, M.D., Ph.D., director of pediatric hematology/oncology and stem cell transplantation at Cohen Children's Medical Center of New York. Dr. Lipton is a member of the St. Baldrick's board of directors, and as scientific chair, spearheaded the creation of the Foundation's grant program to fund childhood cancer research.

Three panels included perspectives from a total of 11 panelists:

Power of the Patient

Taking Childhood Back from Cancer: The Promise of Immunotherapy

Research Powered by Collaboration: Creating Cures and Treatments

The briefing provided an opportunity for the cancer community, Congress and industry representatives to engage in conversation about the necessary innovation for pediatric oncology drug development.

"I'm grateful for the work of the St. Baldrick's Foundation to give pediatric cancer research the attention it needs," said Rubio. "Along with the RACE for Children Act, advances in medical technology will accelerate new, innovative treatments for childhood cancer. We must continue to work together to ensure children are not left out of 21st century research and medicine."

"It's critical that we provide Coloradans and Americans with access to the most innovative treatments," said Bennet. "We will continue the conversation on how to modernize the FDA and bring breakthroughs to those who need them most, especially for the thousands of families with children fighting cancer."

Senators Rubio and Bennet were strong supporters of the Research to Accelerate Cures and Equity  (RACE) for Children Act, which became law in August 2017 and will allow for further drug development and research of pediatric cancer, as well as the Childhood Cancer Survivorship Treatment Access and Research (STAR) Act, the most comprehensive childhood cancer legislation ever taken up by Congress. The STAR Act focuses on maximizing childhood cancer survivors' quality of life, moving childhood cancer research forward and helping kids get access to lifesaving treatments.

"We thank Senators Rubio and Bennet for serving as honorary Congressional hosts for the first St. Baldrick's briefing on the Hill," said Kathleen Ruddy, CEO of the St. Baldrick's Foundation. "It's important that we continue to collaborate and discuss the needs within the childhood cancer community, and push for more research funding for proven innovative treatments such as immunotherapy. Immunotherapy has the power to save children's lives, in the most powerful way yet, while offering the ability to preserve the child's physical and intellectual potential as well."

The St. Baldrick's Foundation, Rubio and Bennet plan to continue to work together to bring awareness and progress to the childhood cancer research community in order to find better treatments as unique as each child.

About St. Baldrick's Foundation
As the largest private funder of childhood cancer research grants, the St. Baldrick's Foundation believes that kids are special and deserve to be treated that way. St. Baldrick's is leading the charge to take childhood back from cancer by funding some of the most brilliant childhood cancer research experts who are working to find cures and better treatments for all childhood cancers. Kids need treatments as unique as they are ? and that starts with funding research just for them. Join us at StBaldricks.org to help support the best cancer treatments for kids.

SOURCE St. Baldrick's Foundation


These press releases may also interest you

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...



News published on and distributed by: